Please use this identifier to cite or link to this item: https://biore.bio.bg.ac.rs/handle/123456789/3182
DC FieldValueLanguage
dc.contributor.authorLukic, J.en_US
dc.contributor.authorJancic, I.en_US
dc.contributor.authorMirkovic, N.en_US
dc.contributor.authorBufan, B.en_US
dc.contributor.authorDjokic, J.en_US
dc.contributor.authorMilenkovic, M.en_US
dc.contributor.authorBegovic, J.en_US
dc.contributor.authorStrahinic, I.en_US
dc.contributor.authorLozo, J.en_US
dc.date.accessioned2019-11-05T13:48:44Z-
dc.date.available2019-11-05T13:48:44Z-
dc.date.issued2017-01-01-
dc.identifier.issn1876-2883-
dc.identifier.urihttps://biore.bio.bg.ac.rs/handle/123456789/3182-
dc.description.abstract© 2017 Wageningen Academic Publishers. In the light of the increasing resistance of bacterial pathogens to antibiotics, one of the main global strategies in applied science is development of alternative treatments, which would be safe both for the host and from the environmental perspective. Accordingly, the aim of this study was to test whether two lactic acid bacteria (LAB) strains, Lactococcus lactis BGBU1-4 and Lactobacillus salivarius BGHO1, could be applied as safe supplements for Listeria infection. Two major research objectives were set: to compare the effects of BGBU1-4 and BGHO1 on early immune response in gut tissue of Wistar rats co-administered with Listeria monocytogenes ATCC19111 and next, to test how this applies to their usage as therapeutics in acute ATCC19111 infection. Intestinal villi (IV), Peyer's patches (PP) and mesenteric lymph nodes (MLN) were used for the analysis. The results showed that BGHO1 increased the mRNA expression of innate immune markers CD14, interleukin (IL)-1β and tumour necrosis factor (TNF)-α in PP and IV, and, in parallel, caused a decrease of listeriolysin O (LLO) mRNA expression in same tissues. In MLN of BGHO1 treated rats, LLO expression was increased, along with an increase of the expression of OX-62 mRNA and CD69, pointing to the activation of adaptive immunity. On the other hand, in BGBU1-4 treated rats, there was no reduction of LLO mRNA expression and no induction of innate immunity markers in intestinal tissue. Additionally, CD14 and IL-1β, as well as LLO, but not OX-62 mRNA and CD69 expression, were elevated in MLN of BGBU1-4 treated rats. However, when applied therapeutically, both, BGBU1-4 and BGHO1, lowered Listeria count in spleens of infected rats. Our results not only reveal the potential of LAB to ameliorate Listeria infections, but suggest different immunological effects of two different LAB strains, both of which could be effective in Listeria elimination.en_US
dc.language.isoenen_US
dc.relation.ispartofBeneficial Microbesen_US
dc.subjectCD14en_US
dc.subjectCD69en_US
dc.subjectLactic acid bacteriaen_US
dc.subjectListeriolysinen_US
dc.titleLactococcus lactis and Lactobacillus salivarius differently modulate early immunological response of Wistar rats co-administered with Listeria monocytogenesen_US
dc.typeArticleen_US
dc.identifier.doi10.3920/BM2017.0007-
dc.identifier.pmid28856909-
dc.identifier.scopus2-s2.0-85031408529-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85031408529-
item.cerifentitytypePublications-
item.grantfulltextrestricted-
item.openairetypeArticle-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
crisitem.author.deptChair of Biochemistry and Molecular Biology-
crisitem.author.orcid0000-0001-9888-5270-
Appears in Collections:Journal Article
Files in This Item:
File Description SizeFormat Existing users please
Lukic et al_2017_BM.pdfLukic et al_2017_BM1.39 MBAdobe PDF
    Request a copy
Show simple item record

SCOPUSTM   
Citations

14
checked on May 5, 2024

Page view(s)

10
checked on May 12, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.